Category: AngioDynamics Inc.
AngioDynamics names Concert Medical president Howard Donnelly as chairman, replacing Vincent Bucci, who stepped down last month.
AngioDynamics (NSDQ:ANGO) said today that it tapped Concert Medical president Howard Donnelly to replace outgoing chairman Vincent Bucci.
Bucci, 1st named to the AngioDynamics board in 2007, was named chairman later that year. He stepped down in March.
AngioDynamics reports a profitable fiscal 3rd quarter and nearly doubles Wall Street's earnings forecast, but shares slide anyway.
AngioDynamics (NSDQ:ANGO) put some black ink in the ledger during its fiscal 3rd quarter and handily topped Wall Street's earnings forecast, but investors have remained unmoved, sending ANGO shares down 12% since its April 9 earnings release.
AngioDynamics wins a nearly $75 million judgment against erstwhile partner Biolitec AG over an alleged scheme to evade U.S legal jurisdiction.
New York's AngioDynamics wins updated labeling from FDA regulators, indicating its AngioVac venous drainage system for up to 6 hours at a time.
AngioDynamics (NSDQ:ANGO) tallied a new win for its AngioVac drainage system, with new FDA clearance to market the device for extended use.
New York's AngioDynamics lands FDA clearance for a new BioFlo product and takes charge of distribution partner Medcomp's Celerity tip locater after an FDA loss.
Biolitec AG appeals a Massachusetts federal judge's issuance of an arrest warrant for its CEO and a $63 million sanction in its legal war with AngioDynamics.
New York's AngioDynamics closes the books on an employee discrimination lawsuit with neither party admitting wrongdoing.
Medtech maker AngioDynamics (NSDQ:ANGO) finally put to bed a former employee's discrimination lawsuit, ending the quarrel with neither party admitting to any wrongdoing.